Clostridioides difficile infection (CDI): A pan-European multi-center cost and resource utilization study, results from the Combatting Bacterial Resistance in Europe CDI (COMBACTE-CDI)

Sebastian Wingen‐Heimann, Kerrie Davies, Virginie Viprey, Georgina Davis, Georgina Davis, Maria J. G. T. Vehreschild, Lise Lurienne, Pierre-Alain Bandinelli, Oliver A. Cornely, Tuba Vilken, Sina M. Hopff, Jörg Janne Vehreschild, Academic Partners, Marc J. M. Bonten, Kerrie Davies, Kerrie A. Davies, Ed J. Kuijper, Maja Rupnik, Sebastian Wingen‐Heimann, Evelina Tacconelli, Tuba Vilken, Nicola Petrosillo, EFPIA Partners, Pfizer Ltd, EFPIA Partners, Sanofi Pasteur, bioMérieux, Sanofi Pasteur, Philippe Cleuziat, Chris Webber, Philippe Cleuziat, Chris Webber